RAPID MICRO BIOSYSTEMS, INC. Cash Flow Statement
RPID|5 years of annual SEC 10-K data (FY2021-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 5 fiscal years. All figures from audited SEC 10-K filings.
RAPID MICRO BIOSYSTEMS, INC. used $44M in operating cash flow and negative free cash flow of $46M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -64.58 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income | -$46.9M | -$52.5M | -$60.8M | -$73.5M | -$37.1M |
| Depreciation & Amortization | $3.4M | $3.1M | $2.8M | $1.5M | $1.5M |
| Operating Cash Flow | -$44.2M | -$45.1M | -$58.5M | -$55.0M | -$31.0M |
| Capital Expenditures | $1.4M | $1.8M | $6.7M | $3.2M | $690.0K |
| Free Cash Flow | -$45.5M | -$46.9M | -$65.3M | -$58.2M | -$31.7M |
| FCF Margin | -162.3% | -208.4% | -381.1% | -250.4% | -197.1% |